Further highlighting a potential role for GLP-1 analogues in AUD management, a recent cohort study, complemented with a self-controlled case series analysis, suggested that the use of GLP-1 analogues (grouped as a class and prescribed for their currently approved indications) might be associated with lower incidence of alcohol-related events (114). This evidence concerns the gene GLP1R and alcohol drinking.